Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Olaparib Impurity 59 REF: 4Z-O-032064CAS: 16859-59-9	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 21 REF: 4Z-A-8261	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 69 REF: 4Z-O-032074CAS: 477535-39-0	- - -	To inquire	Tue 10 Dec 24
Tamoxifen EP Impurity E REF: 4Z-T-0117	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 56 REF: 4Z-O-032061	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 67 REF: 4Z-C-121070CAS: 868539-99-5	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 70 REF: 4Z-P-196077	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 10 REF: 4Z-P-196014CAS: 2206135-30-8	- - -	To inquire	Tue 10 Dec 24
N- Desmethyl Tamoxifen (E/Z mixture) REF: 4Z-T-0131	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 7 REF: 4Z-L-124010	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 55 REF: 4Z-P-196062CAS: 2444702-87-6	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 11 REF: 4Z-F-3133	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 76 REF: 4Z-O-032082CAS: 763114-25-6	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 39 REF: 4Z-N-066057CAS: 121-95-9	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 35 REF: 4Z-E-068048	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 78 REF: 4Z-O-032084	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 79 REF: 4Z-O-032085CAS: 2558-18-1	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 17 REF: 4Z-F-3125	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 81 REF: 4Z-C-121086	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 4 REF: 4Z-A-8237CAS: 2118-32-3	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Olaparib Impurity 59

Ref: 4Z-O-032064

Abiraterone Impurity 21

Ref: 4Z-A-8261

Olaparib Impurity 69

Ref: 4Z-O-032074

Tamoxifen EP Impurity E

Ref: 4Z-T-0117

Olaparib Impurity 56

Ref: 4Z-O-032061

Carfilzomib Impurity 67

Ref: 4Z-C-121070

Palbociclib Impurity 70

Ref: 4Z-P-196077

Palbociclib Impurity 10

Ref: 4Z-P-196014

N- Desmethyl Tamoxifen (E/Z mixture)

Ref: 4Z-T-0131

Lenvatinib Impurity 7

Ref: 4Z-L-124010

Palbociclib Impurity 55

Ref: 4Z-P-196062

Fulvestrant Impurity 11

Ref: 4Z-F-3133

Olaparib Impurity 76

Ref: 4Z-O-032082

Nintedanib Impurity 39

Ref: 4Z-N-066057

Enzalutamide Impurity 35

Ref: 4Z-E-068048

Olaparib Impurity 78

Ref: 4Z-O-032084

Olaparib Impurity 79

Ref: 4Z-O-032085

Fulvestrant Impurity 17

Ref: 4Z-F-3125

Carfilzomib Impurity 81

Ref: 4Z-C-121086

Abiraterone Impurity 4

Ref: 4Z-A-8237